BioSpace News Archive

Business

UC Berkeley Launches New Molecular Therapeutics Initiative to Accelerate Drug Discovery

The University of California, Berkeley Molecular Therapeutics (MTx) division of the Molecular & Cell Biology department today announced the launch of a new initiative to accelerate drug discovery at the interface of academia and biotech.

March 14, 2024
·
5 min read
Business

Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration

Charles River Laboratories International, Inc. (NYSE: CRL) and Navega Therapeutics , Inc. today announced an AAV9 production program agreement.

March 14, 2024
·
4 min read
Lone Star Bio

Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Autonomix Medical, Inc. today announced the safe completion of the first three patient procedures for its proof-of-concept (PoC) human clinical trial evaluating the use of transvascular RF ablation for the treatment of pancreatic cancer pain.

March 14, 2024
·
4 min read
Lone Star Bio

Form Bio Helps Life Sciences Professionals Transform Omics Data Into Breakthrough Insights Through Google Cloud

Form Bio , the breakthrough computational life sciences solutions provider, today announced the availability of Google Cloud’s innovative AI-based models for healthcare and life sciences research as point-and-click workflows via Form Bio’s bioinformatics platform.

March 14, 2024
·
5 min read
Bio NC

Inhalon Biopharma Announces Two Publications Advancing its Inhaled Antibody Treatment Platform for Acute Respiratory Infections

Inhalon Biopharma today announced the publication of preclinical data showcasing the advantages and efficacy of its “muco-trapping” technology in animal models of respiratory syncytial virus (RSV) and SARS-CoV-2 infections.

March 14, 2024
·
4 min read
Business

Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc. today announced that it will release its financial and business results for the fourth quarter and full year of 2023 after market close on March 28, 2024.

March 14, 2024
·
1 min read
Pharm Country

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

GeneDx today announced its scientific contributions at the 2024 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting.

March 14, 2024
·
4 min read
BioCapital

Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal Science

Telomir Pharmaceuticals, Inc. today highlighted its use of computer-aided testing in a pre-clinical setting to study and analyze the potential benefits of its lead product candidate, Telomir-1.

March 14, 2024
·
4 min read
Biotech Bay

First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG

HeartBeam, Inc. announced today that it has enrolled the first patients in the VALID-ECG ( Clinical Validation of the AIMIGo 12-Lead ECG Synthesis Software for Arrhythmia Detection ) pivotal study.

March 14, 2024
·
5 min read
BioMidwest

Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session

Cardio Diagnostics Holdings, Inc. announces that the Company will showcase its groundbreaking HeartRisk TM and Actionable Clinical Intelligence TM platforms at the American College of Cardiology’s 73rd Annual Scientific Session (ACC.24), taking place in Atlanta, GA, from April 6-8, 2024.

March 14, 2024
·
5 min read